Is it real?
The non-invasive wearable and analysis system have regulatory clearances and are marketed internationally. Broad clinical adoption, reimbursement and outcome evidence remain the scaling gates.
HEALTHTECH & HUMAN PERFORMANCE · TECHNOLOGY SIGNAL
Gastric Alimetry · Auckland-founded · international markets
The non-invasive wearable and analysis system have regulatory clearances and are marketed internationally. Broad clinical adoption, reimbursement and outcome evidence remain the scaling gates.
Early commercial regulated medical technology.
HOW IT WORKS
A wearable array records gastric electrical activity and combines it with patient symptom data; software and AI analysis help clinicians interpret gastric function.
EVIDENCE BASE
Regulatory clearances have been secured.
The system is marketed in New Zealand, the US and UK.
Adoption and reimbursement vary by health system.
GLOBAL INDUSTRY IMPACT
Wearables are moving from consumer wellness into specialist diagnostics and longitudinal clinical evidence.
NEW ZEALAND RELEVANCE
This is a strong NZ pathway from university research through medical-device engineering, AI analysis, regulation and entry into much larger health markets.
IMPLICATIONS FOR NZ TECHNOLOGY
PARTICIPATION PATHS
LIMITS & RISKS
NEXT SIGNALS
PRIMARY EVIDENCE